Miguel Escalon
Physical Medicine & Rehabilitation · New York, NYNPI 1124256466
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.4%), consulting fees and gifts — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Ipsen Biopharmaceuticals, Inc at 42.1% of the total. Reporting peaked in 2021 at $3,954 and has fallen 75.0% since, to $987 in 2025. Among physical medicine & rehabilitation clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $84.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$4K
- Merz Pharmaceuticals, LLC$2K
- AbbVie$2K
- Saol Therapeutics Inc.$792
- Merz North America, Inc.$531
- Pacira Pharmaceuticals Incorporated$283
Across 4 payments — averaging $591.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pacira Pharmaceuticals Incorporated$2K
What the payments were for
- Consulting fees$3,93843%
- Food & beverage$4,43648%
- Gifts$7929%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 11 | $3,859 |
| Merz Pharmaceuticals, LLC | 40 | $2,053 |
| AbbVie(2 entities) | 39 | $1,648 |
| Saol Therapeutics Inc. | 4 | $792 |
| Merz North America, Inc. | 10 | $531 |
| Pacira Pharmaceuticals Incorporated | 4 | $283 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,165 in reported general payments places this provider in the 95th percentile of 872 physical medicine & rehabilitation providers in New York.
See all physical medicine & rehabilitation providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 21 | $9,243 |
| Xtampza ErOxycodone Myristate | 13 | $8,709 |
| LyricaPregabalin | 19 | $7,320 |
| Baclofen | 144 | $6,124 |
| Methenamine Hippurate | 24 | $2,194 |
| Gabapentin | 123 | $2,004 |
| Oxycodone Hcl | 54 | $1,285 |
| Pregabalin | 40 | $1,164 |
| AmantadineAmantadine Hcl | 21 | $1,052 |
| Midodrine Hcl | 32 | $1,010 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $945 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $858 |
| Oxybutynin Chloride ErOxybutynin Chloride | 30 | $805 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $690 |
| Ketoconazole | 11 | $653 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in New York
- Heidi FuscoNew York$153K
- Michael OdellNew York$67K
- Craig AntellNew York$65K
- Michael StubblefieldNew York$53K
- Heakyung KimNew York$53K
- Russell SilverNew York$34K
- Julia IafrateNew York$32K
- Neil JaseyNew York$29K
- Christian CustodioNew York$19K
- Karan JoharNew York$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.